Cited by 92Computational Drug Discovery MethodsMachine Learning in BioinformaticsBioinformatics and Genomic Networks

DeepCPI: A Deep Learning-Based Framework for Large-Scale in Silico Drug Screening

Open access
Wan, Fangping, Zhu, Yue, Hu, Hailin, Dai, Antao, Cai, Xiaoqing, Chen, Ligong, Gong, Haipeng, Xia, Tian +3 more·2019·Genomics, Proteomics & Bioinformatics

Abstract

Accurate identification of compound-protein interactions (CPIs) in silico may deepen our understanding of the underlying mechanisms of drug action and thus remarkably facilitate drug discovery and development. Conventional similarity- or docking-based computational methods for predicting CPIs rarely exploit latent features from currently available large-scale unlabeled compound and protein data and often limit their usage to relatively small-scale datasets. In the present study, we propose DeepCPI, a novel general and scalable computational framework that combines effective feature embedding (a technique of representation learning) with powerful deep learning methods to accurately predict CPIs at a large scale. DeepCPI automatically learns the implicit yet expressive low-dimensional features of compounds and proteins from a massive amount of unlabeled data. Evaluations of the measured CPIs in large-scale databases, such as ChEMBL and BindingDB, as well as of the known drug-target interactions from DrugBank, demonstrated the superior predictive performance of DeepCPI. Furthermore, several interactions among small-molecule compounds and three G protein-coupled receptor targets (glucagon-like peptide-1 receptor, glucagon receptor, and vasoactive intestinal peptide receptor) predicted using DeepCPI were experimentally validated. The present study suggests that DeepCPI is a useful and powerful tool for drug discovery and repositioning. The source code of DeepCPI can be downloaded from https://github.com/FangpingWan/DeepCPI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gpb.2019.04.003

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prediction of drug-target interactions in small-molecule drug discovery is largely driven by significant improvement in the performance of computational methods.

    “This is analogous to small-molecule drug discovery, where computational methods have already made significant inroads [5,6]; prediction of drug-target interactions in particular is largely driven by the significant improvement in the performance of computational methods.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 74 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [20]Unterthiner T. Mayr A. Klambauer G. Steijaert M. Wegner J.K. Ceulemans H. Deep learning as an opportunity in virtual screening Workshop Deep Learn Represent Learn 27 2014 1 9

Cited by

Sorted by citations

Authors
Wan, F., Zhu, Y., Hu, H., Dai, A., Cai, X., Chen, L., Gong, H., Xia, T., Yang, D., Wang, M.-W., & Zeng, J.
Affiliations
  • Institute for Interdisciplinary Information Sciences, Tsinghua University , Beijing 100084 , China
  • Chinese Academy of Sciences (CN)
  • Tsinghua University (CN)
  • Huazhong University of Science and Technology (CN)
  • Shanghai Medical College of Fudan University (CN)
Corresponding author
  • Yang, Dehua
  • Wang, Ming-Wei
  • Zeng, Jianyang
Venue
Genomics, Proteomics & Bioinformatics
Published
2019-10-01
Volume
17
Issue
5
Pages
478-495
ISSN
  • 1672-0229 (ISSN-L)
  • 2210-3244
OpenAlex
W3005064662
Cited by
92
References
74
Citations by year
2026: 7 · 2025: 12 · 2024: 20 · 2023: 19 · 2022: 13 · 2021: 12 · 2020: 8
FWCI
5.60
Type
journal article
Language
en
Open access
Locations
  • Genomics Proteomics & Bioinformatics (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (61872216, 81630103 to JZ, 81872915 to MWW, 81573479, 81773792 to DY, 81630103, 81872915, 81773792)
  • National Science and Technology Major Project (2018ZX09711003-004-002 to LC, 2018ZX09711003-004-002)
  • National Science and Technology Major Project Key New Drug Creation and Manufacturing Program of China (2018ZX09735-001 to MWW, 2018ZX09711002-002-005 to DY)
  • Shanghai Science and Technology Development Fund (15DZ2291600 to MWW, 16ZR1407100 to AD, 15DZ2291600, 16ZR1407100)
  • Key New Drug Creation and Manufacturing Program (2018ZX09735-001, 2018ZX09711002-002-005)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
compound-protein interactions, in silico drug screening, feature embedding, representation learning, drug-target interactions, G protein-coupled receptors, GLP-1 receptor, glucagon receptor, vasoactive intestinal peptide receptor, drug repurposing, drug discovery
MeSH terms
Deep Learning, Pharmaceutical Preparations, Proteins, ROC Curve, User-Computer Interface, Area Under Curve, Databases, Chemical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review